SCHEMBL23054306

SCHEMBL23054306

CCC(CC)N(C)S(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AGER Q15109 1/20 0.62
▸ MAPT P10636 1/20 0.52
▸ MCOLN3 Q8TDD5 1/20 0.52
▸ C5AR1 P21730 1/20 0.49
▸ CA12 O43570 1/20 0.47
▸ CA9 Q16790 1/20 0.47
▸ PSEN1 P49768 1/20 0.47
▸ PSEN2 P49810 1/20 0.47
▸ APH1B Q8WW43 1/20 0.47
▸ NCSTN Q92542 1/20 0.47
▸ APH1A Q96BI3 1/20 0.47
▸ PSENEN Q9NZ42 1/20 0.47
▸ GLA P06280 1/20 0.46
▸ ATM Q13315 1/20 0.44
▸ GAA P10253 1/20 0.43
▸ ALDH1A1 P00352 3/20 0.43
▸ HPGD P15428 1/20 0.43
▸ CNR2 P34972 4/20 0.43
▸ KEAP1 Q14145 1/20 0.42
▸ NFE2L2 Q16236 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12180441 0.80 AGER (0.71) AGERMAPTMCOLN3C5AR1CA12
SCHEMBL17481680 0.78 AGER (0.54) AGERMAPTMCOLN3C5AR1CA12
SCHEMBL16603991 0.77 AGER (1.00) AGERMAPTMCOLN3C5AR1CA12
SCHEMBL16603952 0.76 AGER (0.76) AGERMAPTMCOLN3C5AR1CA12
SCHEMBL13434084 0.75 MAPT (0.57) AGERMAPTMCOLN3C5AR1CA12
SCHEMBL26413518 0.73 MAPT (0.65) AGERMAPTMCOLN3C5AR1CA12
SCHEMBL82589 0.73 MAPT (0.65) AGERMAPTMCOLN3C5AR1CA12
SCHEMBL5880406 0.73 MAPT (0.65) AGERMAPTMCOLN3C5AR1CA12
SCHEMBL1142459 0.73 AGER (0.51) AGERMAPTMCOLN3C5AR1CA12
SCHEMBL12169330 0.73 MAPT (0.60) AGERMAPTMCOLN3C5AR1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210060995-A1 THERMAL TRANSFER RECORDING SHEET CANON KABUSHIKI KAISHA (JP) 2021-03-04 — — US disclosed
Send feedback